228 related articles for article (PubMed ID: 30719079)
1. Human tissue kallikrein in the treatment of acute ischemic stroke.
Alexander-Curtis M; Pauls R; Chao J; Volpi JJ; Bath PM; Verdoorn TA
Ther Adv Neurol Disord; 2019; 12():1756286418821918. PubMed ID: 30719079
[TBL] [Abstract][Full Text] [Related]
2. Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins.
Dedio J; Wiemer G; Rütten H; Dendorfer A; Schölkens BA; Müller-Esterl W; Wohlfart P
Biol Chem; 2001 Oct; 382(10):1483-90. PubMed ID: 11727832
[TBL] [Abstract][Full Text] [Related]
3. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
4. Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.
Pizard A; Richer C; Bouby N; Picard N; Meneton P; Azizi M; Alhenc-Gelas F
Biol Chem; 2008 Jun; 389(6):701-6. PubMed ID: 18627303
[TBL] [Abstract][Full Text] [Related]
5. The use of stent retrievers in acute ischemic stroke.
Gill R; Schneck MJ
Expert Rev Neurother; 2016 Aug; 16(8):969-81. PubMed ID: 27219051
[TBL] [Abstract][Full Text] [Related]
6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
7. Rapid Systematic Review: Intra-Arterial Thrombectomy ("Clot Retrieval") for Selected Patients with Acute Ischemic Stroke.
Meurer WJ; Barth BE; Gaddis G; Vilke GM; Lam SH
J Emerg Med; 2017 Feb; 52(2):255-261. PubMed ID: 27863833
[TBL] [Abstract][Full Text] [Related]
8. Endovascular intracranial treatment of acute ischemic strokes.
Rangel-Castilla L; Snyder KV; Siddiqui AH; Levy EI; Hopkins NL
J Cardiovasc Surg (Torino); 2016 Feb; 57(1):36-47. PubMed ID: 26771725
[TBL] [Abstract][Full Text] [Related]
9. Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
Ehrenfeld P; Manso L; Pavicic MF; Matus CE; Borquez C; Lizama A; Sarmiento J; Poblete MT; Bhoola KD; Naran A; Figueroa CD
Anticancer Res; 2014 Dec; 34(12):6925-38. PubMed ID: 25503118
[TBL] [Abstract][Full Text] [Related]
10. Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
Lubeck DP; Danese MD; Duryea J; Halperin M; Tayama D; Yu E; Lalla D; Grotta JC
Int J Stroke; 2016 Feb; 11(2):198-205. PubMed ID: 26783311
[TBL] [Abstract][Full Text] [Related]
11. Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia.
Smith RS; Gao L; Chao L; Chao J
Biol Chem; 2008 Jun; 389(6):725-30. PubMed ID: 18627294
[TBL] [Abstract][Full Text] [Related]
12. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.
Skagen K; Skjelland M; Russell D; Jacobsen EA
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1532-9. PubMed ID: 25922156
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases.
Sexton DJ; Chen T; Martik D; Kuzmic P; Kuang G; Chen J; Nixon AE; Zuraw BL; Forteza RM; Abraham WM; Wood CR
Biochem J; 2009 Aug; 422(2):383-92. PubMed ID: 19527222
[TBL] [Abstract][Full Text] [Related]
14. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.
Campbell DJ
Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095
[TBL] [Abstract][Full Text] [Related]
15. Experimental therapy with tissue kallikrein against cerebral ischemia.
Chao J; Chao L
Front Biosci; 2006 May; 11():1323-7. PubMed ID: 16368519
[TBL] [Abstract][Full Text] [Related]
16. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
Marcondes S; Antunes E
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
[TBL] [Abstract][Full Text] [Related]
17. Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).
Devetzi M; Goulielmaki M; Khoury N; Spandidos DA; Sotiropoulou G; Christodoulou I; Zoumpourlis V
Int J Mol Med; 2018 Mar; 41(3):1177-1186. PubMed ID: 29328364
[TBL] [Abstract][Full Text] [Related]
18. Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors.
Houle S; Molinaro G; Adam A; Marceau F
Hypertension; 2003 Mar; 41(3):611-7. PubMed ID: 12623967
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein gene expression in human pituitary tissues.
Clements JA; Mukhtar A; Verity K; Pullar M; McNeill P; Cummins J; Fuller PJ
Clin Endocrinol (Oxf); 1996 Feb; 44(2):223-31. PubMed ID: 8849579
[TBL] [Abstract][Full Text] [Related]
20. Glandular kallikrein gene expression in the human uterus.
Clements J; Mukhtar A; Ehrlich A; Yap B
Braz J Med Biol Res; 1994 Aug; 27(8):1855-63. PubMed ID: 7749374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
